This information is intended for Healthcare Professionals
You will now be re-directed to www.pfizermedicalinformation.com
Vepdegestrant is an investigational compound. Its safety and efficacy have not been established. * Vepdegestrant is being co-developed with Arvinas.
Breast Cancer
Phase 1
NCT04072952
Phase 2
Phase 3
NCT05909397
Back
